Anti-viral drug remdesivir reduces risk of hospitalization in high-risk COVID-19 patients by 87% when given early Researchers looked at 562 COVID-19 patients in a clinical
Read more
Home »
In a methodologically trailblazing paper published in the journal Nature Genetics, a team of Belgian scientists uncovered an assembly of coronavirus host factors that may
Read more
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly,
Read more
The coronavirus disease 2019 (COVID-19) pandemic – caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – is still causing hundreds of thousands of
Read more
The developers of Sputnik V coronavirus vaccine announced on Tuesday that it had an efficacy rate or 95 per cent based on the second interim
Read more
MONDAY, Nov. 23, 2020 — The use of remdesivir currently is not recommended for hospitalized COVID-19 patients because of the lack of evidence for improvement
Read more
While most people infected with the novel coronavirus actively shed the pathogen for about eight days, scientists have reported an unusual case of a blood
Read more
THURSDAY, Oct. 8, 2020 — Remdesivir has proved its mettle against COVID-19, a final report on the antiviral concludes. Remdesivir hastened recovery for COVID patients
Read more
In an effort to understand why men are at greater risk for more severe symptoms and worse outcomes from COVID-19 regardless of age, scientists at
Read more
The coronavirus pandemic is likely to be a challenge for years to come even with a vaccine, according to pharmaceutical and public-health experts. While a
Read more